The guideline development panel was composed of members and nonmembers of the ACCP who were known to have expertise in various areas of lung cancer management and care, representing multiple specialties, and 13 national and international medical associations (Table 1
), including the Alliance for Lung Cancer Advocacy, Support, and Education (a patient support group) and the Oncology Nurses Society. The specialties included pulmonary/respiratory medicine, critical care, medical oncology, thoracic surgery, radiation oncology, epidemiology, law, and medical ethics. The panel was led by an executive committee including the chair (MA) and vice chair (GC), the leader of the methodology support group (DM), the ACCP project manager (SL), and the vice-president for Health and Science Policy (SP). The executive committee directed the guideline development process, methodological issues, panel composition, structure of the final document, and activities of the topic-specific writing committees.